Vanda Pharmaceuticals
VNDA
#7445
Rank
S$0.52 B
Marketcap
S$8.90
Share price
-2.95%
Change (1 day)
41.38%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2024 the company made an earning of -S$52.4 Million a decrease over its 2023 earnings that were of -S$17.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion202.29%
2024 -S$52.4 Million191.43%
2023 -S$17.98 Million-320.45%
2022 S$8.15 M-84.99%
2021 S$54.32 M54.8%
2020 S$35.09 M19.42%
2019 S$29.39 M4.93%
2018 S$28 M-228.6%
2017 -S$21.78 Million-8.98%
2016 -S$23.93 Million-53.79%
2015 -S$51.78 Million-30.18%
2014 -S$74.16 Million173.08%
2013 -S$27.16 Million-25.33%
2012 -S$36.37 Million163.61%
2011 -S$13.8 Million-221.15%
2010 S$11.38 M-124.53%
2009 -S$46.43 Million-29.44%
2008 -S$65.8 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$84.67 Million170.55%
2005 -S$31.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$43.23 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.06 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.13 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.15 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$28.89 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.01 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.62 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA